"Nvidia's Strategic Investments in Arm, SoundHound, and Biotech Firm Recursion"

Nvidia disclosed investments in Arm Holdings, SoundHound AI, and biotech company Recursion Pharmaceuticals in a 13F form filed with the US Securities and Exchange Commission, revealing its investment strategy following the failed attempt to acquire Arm for $40 billion in 2020. The disclosed stakes led to significant market movements, with Arm up 2% in premarket trading, SoundHound shares soaring 55% in late trading, and Recursion climbing 19% in premarket trading. Nvidia also revealed smaller holdings in Nano-X Imaging Ltd. and TuSimple Holdings Inc., showcasing its diverse investment portfolio in technology and biotech companies.